search
Back to results

Intensive Prevention Program After Myocardial Infarction (IPP)

Primary Purpose

Myocardial Infarction, Prevention Harmful Effects

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Intensive Prevention Program
Standard medical and interventional therapy
Sponsored by
Herzzentrum Bremen
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Myocardial Infarction

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

Hospitalisation due to myocardial infarction (ST-elevation or non-ST-elevation myocardial infarction)

Exclusion Criteria:

i) Hemodynamically significant valvular heart disease (> NYHA class II) or inborn cardiac malformations.

ii) Cardiomyopathy associated with hemodynamic obstruction, pregnancy or myocarditis.

iii) Exercise limitations due to clinical conditions not related to CAD. iv) Any major non-cardiac condition that would adversely effect survival during the duration of the study.

v) Patients unlikely to comply to the study treatment and the follow-up visits. vi) Pregnancy (all pre-menopausal females should have a negative serum pregnancy test).

vii) Inability of cooperation with the protocol, including longterm follow-up. viii) Patient refusal or inability to give informed consent. ix) Refusal of the patient's physician regarding trial participation of the patient.

x) Chronic drug or alcohol abuse.

Sites / Locations

  • Herzzentrum Bremen

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Other

Arm Label

Intensive prevention program

Usual care

Arm Description

Standard care with respect to medical and interventional therapy plus intensive prevention program with "study nurse"-coordinated education sessions, regular telephone calls, telephone hotline and telemetric care of cardiovascular risk factors (if patient internet connection available).

Standard care with respect to medical and interventional therapy.

Outcomes

Primary Outcome Measures

Prevention score (point score of cardiovascular risk factors)
Prevention success
Improvement of one of the risk factors LDL-cholesterol, physical inactivity, smoking without deterioration of another (primary endpoint for IPP-Y = substudy on young MI-patients <= 45 years that was added after completion of the pilot study)

Secondary Outcome Measures

Combined endpoint of clinical adverse events
Adherence to prognostic relevant medication after myocardial infarction

Full Information

First Posted
July 7, 2013
Last Updated
June 20, 2020
Sponsor
Herzzentrum Bremen
Collaborators
Oldenburger Forschungs- und Entwicklungsinstitut für Informatik (OFFIS)., University of Luebeck, Klinikum Oldenburg gGmbH
search

1. Study Identification

Unique Protocol Identification Number
NCT01896765
Brief Title
Intensive Prevention Program After Myocardial Infarction
Acronym
IPP
Official Title
Intensive Longterm Prevention Program After Myocardial Infarction in Northwest Germany
Study Type
Interventional

2. Study Status

Record Verification Date
June 2020
Overall Recruitment Status
Completed
Study Start Date
October 2013 (undefined)
Primary Completion Date
March 2020 (Actual)
Study Completion Date
May 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Herzzentrum Bremen
Collaborators
Oldenburger Forschungs- und Entwicklungsinstitut für Informatik (OFFIS)., University of Luebeck, Klinikum Oldenburg gGmbH

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
It is unknown, if a modern prevention program, including intense nurse-coordinated education sessions, regular telephone contacts and a telephone hotline for 12 months, significantly reduces cardiovascular risk factors, clinical events and quality of life in myocardial infarction patients compared to usual care. Furthermore, actually no data on the additional effects and the feasibility of longterm telemetric care of cardiovascular risk factors exist. The primary hypothesis to be tested is that an intensive longterm prevention program compared to the standard of medical care, will achieve better risk factor control and consecutively less clinical adverse events in patients after myocardial infarctions. The study endpoints will be evaluated after 12 months and during long-term course (after 24 months = one year after termination of the prevention program). In a substudy the effects of short reinterventions ("Prevention Boosts") during long-term course are tested (IPP Prevention Boost Study). Patients with at least one insufficiently controlled risk factor at 24-months visit are randomly assigned to a short (2-month) reintervention vs. no reintervention. The effects of the reinterventions on risk factor control are evaluated after 36 months. A further substudy focusing on young patients <= 45 years of age at time of MI (IPP-Y = IPP in the Young) was added after completion of the pilot IPP study. In this study we focus on the prevention program in young MI-patients. A retrospective analysis of individual genetic risk (assessed by genetic risk scores) in the young patients is included in this substudy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myocardial Infarction, Prevention Harmful Effects

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
300 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Intensive prevention program
Arm Type
Experimental
Arm Description
Standard care with respect to medical and interventional therapy plus intensive prevention program with "study nurse"-coordinated education sessions, regular telephone calls, telephone hotline and telemetric care of cardiovascular risk factors (if patient internet connection available).
Arm Title
Usual care
Arm Type
Other
Arm Description
Standard care with respect to medical and interventional therapy.
Intervention Type
Behavioral
Intervention Name(s)
Intensive Prevention Program
Intervention Description
"Study nurse"-coordinated education sessions, telephone calls, telephone hotline and telemetric care of cardiovascular risk factors (if patient internet connection available).
Intervention Type
Other
Intervention Name(s)
Standard medical and interventional therapy
Intervention Description
Medical and interventional therapy following the standard of care.
Primary Outcome Measure Information:
Title
Prevention score (point score of cardiovascular risk factors)
Time Frame
24 months
Title
Prevention success
Description
Improvement of one of the risk factors LDL-cholesterol, physical inactivity, smoking without deterioration of another (primary endpoint for IPP-Y = substudy on young MI-patients <= 45 years that was added after completion of the pilot study)
Time Frame
24 months
Secondary Outcome Measure Information:
Title
Combined endpoint of clinical adverse events
Time Frame
24 months
Title
Adherence to prognostic relevant medication after myocardial infarction
Time Frame
24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Hospitalisation due to myocardial infarction (ST-elevation or non-ST-elevation myocardial infarction) Exclusion Criteria: i) Hemodynamically significant valvular heart disease (> NYHA class II) or inborn cardiac malformations. ii) Cardiomyopathy associated with hemodynamic obstruction, pregnancy or myocarditis. iii) Exercise limitations due to clinical conditions not related to CAD. iv) Any major non-cardiac condition that would adversely effect survival during the duration of the study. v) Patients unlikely to comply to the study treatment and the follow-up visits. vi) Pregnancy (all pre-menopausal females should have a negative serum pregnancy test). vii) Inability of cooperation with the protocol, including longterm follow-up. viii) Patient refusal or inability to give informed consent. ix) Refusal of the patient's physician regarding trial participation of the patient. x) Chronic drug or alcohol abuse.
Facility Information:
Facility Name
Herzzentrum Bremen
City
Bremen
ZIP/Postal Code
28277
Country
Germany

12. IPD Sharing Statement

Learn more about this trial

Intensive Prevention Program After Myocardial Infarction

We'll reach out to this number within 24 hrs